Freenome, Inc. - Common stock (FRNM)

11.15
+0.24 (2.20%)
NASDAQ· Last Trade: Aug 8th, 6:52 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.91
Open10.90
Bid10.87
Ask11.15
Day's Range10.90 - 11.29
52 Week Range9.970 - 14.26
Volume548,629
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume768,635

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026